Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ANIDULAFUNGIN vs ANTIHEMOPHILIC FACTOR PORCINE, B-DOMAIN TRUNCATED RECOMBINANT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ANIDULAFUNGIN vs ANTIHEMOPHILIC FACTOR PORCINE, B-DOMAIN TRUNCATED RECOMBINANT: Safety Overview

Metric ANIDULAFUNGIN ANTIHEMOPHILIC FACTOR PORCINE, B-DOMAIN TRUNCATED RECOMBINANT
Total FAERS Reports 701 195
Deaths Reported 325 25
Death Rate 46.4% 12.8%
Hospitalizations 287 49
Average Patient Age 53.3 yrs 73.4 yrs
% Female Patients 40.0% 34.0%
FDA Approval Date Feb 17, 2006 N/A
Manufacturer Roerig N/A
Route INTRAVENOUS N/A
Marketing Status Prescription N/A